These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20660775)

  • 1. Anthrax toxin-neutralizing antibody reconfigures the protective antigen heptamer into a supercomplex.
    Radjainia M; Hyun JK; Leysath CE; Leppla SH; Mitra AK
    Proc Natl Acad Sci U S A; 2010 Aug; 107(32):14070-4. PubMed ID: 20660775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Screening of full human anthrax lethal factor neutralizing antibody in transgenic mice].
    Wang X; Chi X; Liu J; Liu W; Liu S; Qiu S; Wen Z; Fan P; Liu K; Song X; Fu L; Zhang J; Yu C
    Sheng Wu Gong Cheng Xue Bao; 2016 Nov; 32(11):1590-1599. PubMed ID: 29034628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing monoclonal antibodies directed against defined linear epitopes on domain 4 of anthrax protective antigen.
    Kelly-Cirino CD; Mantis NJ
    Infect Immun; 2009 Nov; 77(11):4859-67. PubMed ID: 19703971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale structural changes accompany binding of lethal factor to anthrax protective antigen: a cryo-electron microscopic study.
    Ren G; Quispe J; Leppla SH; Mitra AK
    Structure; 2004 Nov; 12(11):2059-66. PubMed ID: 15530370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background.
    Abboud N; Casadevall A
    Clin Vaccine Immunol; 2008 Jul; 15(7):1115-23. PubMed ID: 18480236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2beta2-2beta3 loop of anthrax protective antigen contains a dominant neutralizing epitope.
    Zhang J; Xu J; Li G; Dong D; Song X; Guo Q; Zhao J; Fu L; Chen W
    Biochem Biophys Res Commun; 2006 Mar; 341(4):1164-71. PubMed ID: 16460675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Toxin-neutralizing monoclonal antibodies to the different domains of anthrax protective antigen].
    Xu JJ; Zhang J; Liu SL; Lv TJ; Chen W; Li GL; Ge M; Guo Q
    Wei Sheng Wu Xue Bao; 2005 Dec; 45(6):947-51. PubMed ID: 16496709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of toxin functional domains in anthrax pathogenesis.
    Brossier F; Weber-Levy M; Mock M; Sirard JC
    Infect Immun; 2000 Apr; 68(4):1781-6. PubMed ID: 10722564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the Antigen Capture Pathway in the Induction of a Neutralizing Antibody Response to Anthrax Protective Antigen.
    Verma A; Ngundi MM; Price GA; Takeda K; Yu J; Burns DL
    mBio; 2018 Feb; 9(1):. PubMed ID: 29487236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A therapeutic human antibody against the domain 4 of the Bacillus anthracis protective antigen shows protective efficacy in a mouse model.
    Ahn BE; Bae HW; Lee HR; Woo SJ; Park OK; Jeon JH; Park J; Rhie GE
    Biochem Biophys Res Commun; 2019 Feb; 509(2):611-616. PubMed ID: 30606479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new triple chimeric protein as a high immunogenic antigen against anthrax toxins: theoretical and experimental analyses.
    Abdous M; Hasannia S; Salmanian AH; Shahryar Arab S; Shali A; Alizadeh GA; Hajizadeh A; Khafri A; Mohseni A
    Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):25-31. PubMed ID: 30621469
    [No Abstract]   [Full Text] [Related]  

  • 12. Generation and Characterization of Human Monoclonal Antibodies Targeting Anthrax Protective Antigen following Vaccination with a Recombinant Protective Antigen Vaccine.
    Chi X; Li J; Liu W; Wang X; Yin K; Liu J; Zai X; Li L; Song X; Zhang J; Zhang X; Yin Y; Fu L; Xu J; Yu C; Chen W
    Clin Vaccine Immunol; 2015 May; 22(5):553-60. PubMed ID: 25787135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting the Concept of Targeting Only Bacillus anthracis Toxins as a Treatment for Anthrax.
    Glinert I; Bar-David E; Sittner A; Weiss S; Schlomovitz J; Ben-Shmuel A; Mechaly A; Altboum Z; Kobiler D; Levy H
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4878-85. PubMed ID: 27270276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthrax lethal toxin (LeTx) neutralization by PA domain specific antisera.
    Verma M; Suryanarayana N; Tuteja U; Thavachelvam K; Rao MK; Bhargava R; Shukla S
    Toxicon; 2017 Dec; 139():58-65. PubMed ID: 28919458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity.
    Vitale L; Blanset D; Lowy I; O'Neill T; Goldstein J; Little SF; Andrews GP; Dorough G; Taylor RK; Keler T
    Infect Immun; 2006 Oct; 74(10):5840-7. PubMed ID: 16988263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
    Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW
    Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge model.
    Moayeri M; Leysath CE; Tremblay JM; Vrentas C; Crown D; Leppla SH; Shoemaker CB
    J Biol Chem; 2015 Mar; 290(10):6584-95. PubMed ID: 25564615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model.
    Suryanarayana N; Verma M; Thavachelvam K; Saxena N; Mankere B; Tuteja U; Hmuaka V
    Appl Microbiol Biotechnol; 2016 Oct; 100(19):8439-51. PubMed ID: 27364624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ gastrointestinal protection against anthrax edema toxin by single-chain antibody fragment producing lactobacilli.
    Andersen KK; Marcotte H; Álvarez B; Boyaka PN; Hammarström L
    BMC Biotechnol; 2011 Dec; 11():126. PubMed ID: 22185669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1.
    Rivera J; Nakouzi A; Abboud N; Revskaya E; Goldman D; Collier RJ; Dadachova E; Casadevall A
    Infect Immun; 2006 Jul; 74(7):4149-56. PubMed ID: 16790789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.